In the post-HAART era, long-term cardiovascular complications, including myocardial infarction (MI), peripheral vascular diseases, and stroke, have been frequently reported, and an increasing concern is mounting particularly about the increased risk of acute coronary syndromes associated with new potent antiretroviral combinations.3